3Mast EE, Alter MJ. Epidemiology of viral hepatitis: an overview.Semin Virol, 1993,4:273-283.
4Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. NEJM, 1998,339:61-68.
5Kobayashi Satsuki, Ide Tatsuya, Sata Miehio, et al. Detection of YMDD motif mutations in some lamivudine~untreated asymptomatic hepatitis B virus carriers. J Hepatol, 2001,34 : 584-586.
6Kirishima Toshihiko, Okanoue Takeshi, Daimon Yukiko, et al.Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment. J Hepatol, 2002, 37: 259-265.
4Miyazoe S,Hamasaki K,Nakata K,et al.Influence of interleukin 10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus.Am J Gastroenterol,2002,97(8):2086-2092.
5Guettouche T,Hnatyszyn HJ.Chronic hepatitis B and viral genotype:the clinical significance of determining HBV genotypes.Antivir Ther,2005,10(5):593-604.
6Friedman SL.Mechanisms of hepatic fibrogenesis.Gastroenterology,2008,134(6):1655-1669.
